Search

everythinglearnresearchcommunity

for

Search:↓

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Wigs significantly improve the well-being of people with severe hair loss.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

Younger males with androgenic alopecia face significant psychological impacts but maintain better quality of life.

Female pattern hair loss greatly lowers quality of life, especially in young women.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

PRP treatment for hair loss improves quality of life and emotional well-being.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

The oral contraceptive improved hair and skin quality in women.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Alopecia greatly lowers the quality of life for South African Black women, especially affecting their self-image and social interactions.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.

Hair loss is significantly linked to symptoms like dry hair, scalp issues, addiction to tobacco or coffee, anxiety, and digestive problems.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Cetosomal minoxidil is safer and as effective as alcohol-based minoxidil for male hair loss treatment.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.